# Sexton Biotechnologies, Inc. — Form D

Sexton Biotechnologies, Inc. of INDIANAPOLIS, IN, a company, filed a Form D exempt-offering notice with the SEC on 2019-10-25. The offering totals $5.0M, of which $5.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2019-10-25
- Form: D
- Accession: 0001792289-19-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $5.0M
- Minimum investment: $500K
- Investors: 4
- Date of first sale: 2019-10-01
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-351877

## Issuer

- Name: Sexton Biotechnologies, Inc.
- CIK: 0001792289
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 1102 INDIANA AVE., INDIANAPOLIS, IN, 46202
- Phone: (812) 339-2235

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Eli Casdin | Director | New York, NY |
| Doug Dayhoff | Director | Indianapolis, IN |
| Brad King | Director | Indianapolis, IN |
| Mike Rice | Director | Santa Fe, NM |
| Sean Werner | Director | Indianapolis, IN |
| Sean Werner | Executive Officer | Indianapolis, IN |

## More

- [CIK 1792289 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1792289&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001792289-19-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.